These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16842086)

  • 21. Structural analogues of the calanolide anti-HIV agents. Modification of the trans-10,11-dimethyldihydropyran-12-ol ring (ring C).
    Zembower DE; Liao S; Flavin MT; Xu ZQ; Stup TL; Buckheit RW; Khilevich A; Mar AA; Sheinkman AK
    J Med Chem; 1997 Mar; 40(6):1005-17. PubMed ID: 9083491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of HIV-1 reverse transcriptase and HIV-1 replication by Calophyllum coumarins and xanthones.
    Dharmaratne HR; Tan GT; Marasinghe GP; Pezzuto JM
    Planta Med; 2002 Jan; 68(1):86-7. PubMed ID: 11842340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches.
    Tarrago-Litvak L; Andreola ML; Fournier M; Nevinsky GA; Parissi V; de Soultrait VR; Litvak S
    Curr Pharm Des; 2002; 8(8):595-614. PubMed ID: 11945161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS).
    De Clercq E
    Adv Pharmacol; 2013; 67():317-58. PubMed ID: 23886005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural requirements for potent anti-human immunodeficiency virus (HIV) and sperm-immobilizing activities of cyclohexenyl thiourea and urea non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    D'Cruz OJ; Venkatachalam TK; Mao C; Qazi S; Uckun FM
    Biol Reprod; 2002 Dec; 67(6):1959-74. PubMed ID: 12444075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Advances in novel anti-HIV-1 drugs and drug candidates: 2005-2008].
    Zheng PR; Xue H; Xiao ZY; Liu G
    Yao Xue Xue Bao; 2010 Feb; 45(2):154-64. PubMed ID: 21351426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones.
    Budihas SR; Gorshkova I; Gaidamakov S; Wamiru A; Bona MK; Parniak MA; Crouch RJ; McMahon JB; Beutler JA; Le Grice SF
    Nucleic Acids Res; 2005; 33(4):1249-56. PubMed ID: 15741178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dipyridodiazepinone analogs as human immunodeficiency virus type 1-specific non-nucleoside reverse transcriptase inhibitors: an overview.
    Lv M; Xu H
    Curr Med Chem; 2010; 17(18):1874-98. PubMed ID: 20377515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newly approved integrase inhibitors for clinical treatment of AIDS.
    Gu WG
    Biomed Pharmacother; 2014 Oct; 68(8):917-21. PubMed ID: 25451165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-human immunodeficiency virus (anti-HIV) natural products with special emphasis on HIV reverse transcriptase inhibitors.
    Ng TB; Huang B; Fong WP; Yeung HW
    Life Sci; 1997; 61(10):933-49. PubMed ID: 9296332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles.
    Roth T; Morningstar ML; Boyer PL; Hughes SH; Buckheit RW; Michejda CJ
    J Med Chem; 1997 Dec; 40(26):4199-207. PubMed ID: 9435891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-AIDS agents part 41: synthesis and anti-HIV activity of 3',4'-di-o-(-)-camphanoyl-(+)-cis-khellactone (DCK) lactam analogues.
    Yang ZY; Xia Y; Xia P; Brossi A; Cosentino LM; Lee KH
    Bioorg Med Chem Lett; 2000 May; 10(10):1003-5. PubMed ID: 10843202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV reverse transcriptase inhibitors of natural origin.
    Matthée G; Wright AD; König GM
    Planta Med; 1999 Aug; 65(6):493-506. PubMed ID: 10483367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards the design and development of agents with broad spectrum chemotherapeutic properties for the effective treatment of HIV / AIDS.
    Sriram D; Yogeeswari P
    Curr Med Chem; 2003 Sep; 10(17):1689-95. PubMed ID: 12871117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and anti-human immunodeficiency virus activity of the skeleton isomers of 3',4'-Di-(O)-(-)-camphanoyl-(+)-khellactone.
    Nishioka H; Uesugi K; Ueda N; Kondo Y; Tsuji M; Abe H; Harayama T; Hamasaki T; Baba M; Takeuchi Y
    Chem Pharm Bull (Tokyo); 2011; 59(8):1075-6. PubMed ID: 21804260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors.
    Santos LH; Ferreira RS; Caffarena ER
    Mem Inst Oswaldo Cruz; 2015 Nov; 110(7):847-64. PubMed ID: 26560977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of HIV-1 reverse transcriptase and integrase dual inhibitors: Recent advances and developments.
    Gill MSA; Hassan SS; Ahemad N
    Eur J Med Chem; 2019 Oct; 179():423-448. PubMed ID: 31265935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational studies and drug design for HIV-1 reverse transcriptase inhibitors of 3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) analogs.
    Chen HF; Fan BT; Zhao CY; Xie L; Zhao CH; Zhou T; Lee KH; Allaway G
    J Comput Aided Mol Des; 2005 Apr; 19(4):243-58. PubMed ID: 16163451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-AIDS agents 87. New bio-isosteric dicamphanoyl-dihydropyranochromone (DCP) and dicamphanoyl-khellactone (DCK) analogues with potent anti-HIV activity.
    Liu HS; Xu SQ; Cheng M; Chen Y; Xia P; Qian K; Xia Y; Yang ZY; Chen CH; Morris-Natschke SL; Lee KH
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5831-4. PubMed ID: 21871800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity and resistance to (+)-calanolide A of wild-type and mutated forms of HIV-1 reverse transcriptase.
    Quan Y; Motakis D; Buckheit R; Xu ZQ; Flavin MT; Parniak MA; Wainberg MA
    Antivir Ther; 1999; 4(4):203-9. PubMed ID: 10723499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.